Aarti Drugs Ltd. Conference Calls and Earnings Call Transcripts

This has with reference to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 kindly note that Mr. Adhish P. Patil, Chief Financial Officer of the Company had attended the conference 'THE AMSEC CONNECT-2' organised by Asian Markets Securities Pvt. Ltd. (AMSEC) on September 9, 2020.

pdf

Aarti Drugs Ltd.

02 Sep 2020

509.95

3.57%

Earnings Call

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

This has with reference to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 kindly note that Mr. Adhish P. Patil, Chief Financial Officer of the Company had attended 'Ashwamedh, Elara India Virtual Dialogue 2020' on 1st and 2nd September, 2020.

pdf

Aarti Drugs Ltd.

27 Jul 2020

509.95

3.57%

Earnings Call Transcript - Q1FY21 for Aarti Drugs

Conference Call with Aarti Drugs Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.

Aarti Drugs Ltd.

18 May 2020

509.95

3.57%

Earnings Call Transcript - Q4FY20 for Aarti Drugs

Conference Call with Aarti Drugs Management and Analysts on Q4FY20 and Full Year Earnings Performance and Outlook. Listen in to the full earnings transcript.

Aarti Drugs Ltd.

24 Dec 2019

509.95

3.57%

Earnings Call

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

This is to inform you that Mr. Adhish P. Patil, Chief Financial Officer of the Company had a meeting with Senior Research Analyst of Phillip Capital (India) Private Limited on December 23, 2019.

pdf

Aarti Drugs Ltd.

18 Dec 2019

509.95

3.57%

Earnings Call

Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Regulation 30(6) of SEBI (LODR) Regulations, 2015

pdf

Aarti Drugs Ltd. Conference Calls and Earnings Call Transcripts